10,11-Secoergoline
| Names | |
|---|---|
| IUPAC name
3-(piperidin-2-ylmethyl)-1H-indole | |
| Other names
3-(2-Piperidylmethyl)indole; α,N-Tetramethylenetryptamine; α,N-Piperidinyltryptamine; α,N-Pip-T | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C14H18N2 | |
| Molar mass | 214.31 g/mol |
| Pharmacology | |
| Drug class | Simplified/partial ergoline |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
10,11-Secoergoline, also known as 3-(2-piperidylmethyl)indole or as α,N-tetramethylenetryptamine, is the structure of ergoline in which the bond between the 10 and 11 positions of the ring system has been broken to unconstrain the molecule. It is also a tryptamine with the amine cyclized into a piperidine ring connected to the α position.
A notable derivative of 10,11-secoergoline is CT-5252 (methyl-12-bromo-8,9-didehydro-2,3β-dihydro-6-methyl-10,11-secoergoline-8-carboxylate), which is an analogue of lysergic acid diethylamide (LSD) with some of the same behavioral effects in animals but with much lower potency.